Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Diamedica Therapeutics (DMAC – Research Report) today. The company’s shares closed yesterday at $6.61. See what stocks are ...
Through their vision and collaboration with DMAC Architecture & Interiors ... stone fireplace at the entrance pays homage to Taliesin East, the home and studio of Frank Lloyd Wright on the Wisconsin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback